Oxygen therapy: 50 years of uncertainty

Win Tin¹

Affiliations

Comment

Win Tin. Pediatrics. 2002 Sep.

. 2002 Sep;110(3):615-6.

doi: 10.1542/peds.110.3.615.

Win Tin¹

¹ James Cook University Hospital, Middlesbrough, TS4 3BW, United Kingdom. win.tin@stees.nhs.uk

No abstract available

Comment in

Resolving our uncertainty about oxygen therapy.
Cole CH, Wright KW, Tarnow-Mordi W, Phelps DL; Pulse Oximetry Saturation Trial for Prevention of Retinopathy of Prematurity Planning Study Group. Cole CH, et al. Pediatrics. 2003 Dec;112(6 Pt 1):1415-9. doi: 10.1542/peds.112.6.1415. Pediatrics. 2003. PMID: 14654618 No abstract available.

Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes.
[No authors listed] [No authors listed] Pediatrics. 2000 Feb;105(2):295-310. doi: 10.1542/peds.105.2.295. Pediatrics. 2000. PMID: 10654946 Clinical Trial.
Retinopathy of prematurity outcome in infants with prethreshold retinopathy of prematurity and oxygen saturation >94% in room air: the high oxygen percentage in retinopathy of prematurity study.
McGregor ML, Bremer DL, Cole C, McClead RE, Phelps DL, Fellows RR, Oden N; HOPE-ROP Multicenter Group. High Oxygen Percentage in Retinopathy of Prematurity study. McGregor ML, et al. Pediatrics. 2002 Sep;110(3):540-4. doi: 10.1542/peds.110.3.540. Pediatrics. 2002. PMID: 12205257